Poland· PL-100313470
Yttriga
A antiinflammatory agents product containing yttrii (90y) chloridum, registered in Poland by Eckert & Ziegler Radiopharma GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Yttrii (90Y) chloridum
- Manufacturer
- Eckert & Ziegler Radiopharma GmbH
- Country
- Poland (PL)
- ATC code
- V10A
- ATC class
- ANTIINFLAMMATORY AGENTS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcf64bde-b283-40c6-8083-da512a912188 GET /v1/drugs/bcf64bde-b283-40c6-8083-da512a912188?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prekursor radiofarmaceutyczny, roztwór",
"source": "urpl",
"strength": "01-300 GBq",
"packaging": "Rpz ¦ EU/1/05/322/001 ¦ 90478\n1 fiol. \nRpz ¦ EU/1/05/322/002 ¦ 131298\n1 fiol.",
"substance": "Yttrii (90Y) chloridum 01-300 GBq",
"common_name": "Yttrii (90Y) chloridum",
"pl_product_id": "100313470",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about yttrii (90y) chloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.